asbestos lawyers - Worthington & Caron, PC

Over $2.5 billion

obtained for mesothelioma patients & families

Fight Mesothelioma

Recent Posts in Fight Mesothelioma Category

125 results found. Viewing page 1 of 5. Go to page 1 2 3 4 5   Next
Feb 3 2023

Appeals Court Rejects J&J's Controversial Bankruptcy Plan

In a win for mesothelioma plaintiffs, a three-judge panel in the Federal Appeals Court/Third Circuit court of Philadelphia has unanimously ruled that Johnson & Johnson cannot use bankruptcy to sidestep more than 40,000 talcum-powder lawsuits. A ...

Continue Reading...
Jan 13 2023

Novel Combination of Immunotherapy Drug and Radiation Therapy Shown to be Safe

A Phase 1 safety study of single-agent immunotherapy drug, Avelumab, combined with stereotactic body radiation therapy (SBRT) was well-tolerated by mesothelioma patients with no severe side effects. The study was led by researchers from Memorial ...

Continue Reading...
Dec 2 2022

Asbestos Contaminated Potting Soil

Experienced gardeners and green thumb amateurs alike have all encountered potting soil mixes. What they may not realize is that one of the top three ingredients in potting soil, vermiculite, not only takes a carbon-intensive toll on the environment ...

Continue Reading...
Nov 3 2022

Disclosure of the Hazardous Use of Asbestos at Chemical Plant May Pave Way for a Complete Ban

ProPublica has released a must-read investigative report on the remaining hold-out in the total ban of asbestos in America, the chlor-alkali industry. Specifically, two chemical companies, OxyChem and Olin Corp., whose insistence upon using ...

Continue Reading...
Oct 20 2022

PMC Presents: Diamonds are Forever Casino Evening

Join us to support the Pacific Mesothelioma Center and enjoy a luxurious evening at the historic Taglyan Complex with games, dinner and drinks, entertainment, and a live and silent auction with magnificent prizes. In addition to raising greater ...

Continue Reading...
Oct 6 2022

Worthington & Caron is Top-Fundraiser at PMC's 11th Annual Walk/Hike for Mesothelioma!

Hikers gathered on a beautiful, clear Sunday last month to commemorate the Pacific Mesothelioma Center’s 11th Annual Walk/Hike for Mesothelioma. In-person participants were greeted by ample sunshine and expansive city and mountain views atop ...

Continue Reading...
Sep 22 2022

French Health Agency Announces Link between Asbestos Exposure and Laryngeal and Ovarian Cancers

The French National Health Security Agency (ANSES) issued a press release September 19, 2022, announcing a link between asbestos exposure and laryngeal and ovarian cancers. According to ANSES, between 150 to 170 diagnosis of these cancers each year ...

Continue Reading...
Sep 15 2022

Study Utilizing 'Drug Factory' Implants Destroy Mesothelioma Tumors in Mice

Researchers from Rice University and Baylor College of Medicine have managed to eradicate advanced-stage mesothelioma tumors within days on rodent subjects, laying the groundwork for future human trials. By combining cytokine “drug ...

Continue Reading...
Aug 18 2022

Justice for Asbestos Victims: The Removal Adjustment Act

U.S. Representative Elaine Luria of Virginia has introduced legislation to prohibit state courts from removing cases to the federal court system. Throughout the United States, when asbestos victims seek restitution from the companies that knowingly ...

Continue Reading...
Jul 28 2022

Register Now for PMC's 11th Annual 5k Walk/Hike for Mesothelioma and Get Fundraising!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is less than a month away! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills (family and animal ...

Continue Reading...
Jul 21 2022

FDA Grants Fast Trak Status to Novel Therapy for Patients with Unresectable NF2-Deficient Malignant Pleural Mesothelioma

The U.S. Food and Drug Administration (FDA) has designated Fast Track status to a new therapeutic drug therapy for the treatment of malignant pleural mesothelioma (MPM) in patients with unresectable NF2-deficient tumors. The drug, IK-930, was granted ...

Continue Reading...
Jun 23 2022

Should Workplace Asbestos Exposure be Less Protected than the General Population?

When it comes to asbestos cancer risks, should workers be treated differently than the general population? That is the question posed in a recent blog opinion published by the Environmental Defense Fund. Unfortunately, the EPA ’s recently ...

Continue Reading...
Jun 10 2022

Carbon Nanotubes Mimic Asbestos Fibers

Nanotechnology has revolutionized multiple industries in its broad application across medical, industrial, consumer and technological sectors. However, certain types of nanotechnology, such as carbon nanotubes (CNTs), have been shown to closely ...

Continue Reading...
Jun 9 2022

Galinpepimut-S in the Treatment of Late-Stage Pleural Mesothelioma

SELLAS Life Sciences Group (SELLAS) has announced promising results of a Phase 1 clinical trial of the combination of immunotherapy agents Galinpepimut-S (GPS) and nivolumab for patients with WT1 positive malignant pleural mesothelioma. GPS is an ...

Continue Reading...
Jun 6 2022

Researchers Seek to Develop Inhalable Treatment Option for Mesothelioma & Non-Small Cell Lung Cancer

Researchers in Japan are working to develop an inhalable powder as a new form of treatment for non-small cell lung cancer and mesothelioma. The inhalable powder is a form of gene therapy containing tumor suppression drugs SFD-p16 and SFD-p53 which ...

Continue Reading...
Jun 2 2022

Mesothelioma Deaths Among Women Increases

Despite the overall decreased use of asbestos nationwide, mesothelioma deaths among women still managed to increase by 25% over the past two decades. This according to death record statistics published by the Centers for Disease Control and ...

Continue Reading...
May 20 2022

Tazemetostat Proves Effective in Treatment of Mesothelioma with BAP1 Mutation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...

Continue Reading...
May 19 2022

Johnson & Johnson's Bankruptcy Plan to be Reviewed by Appellate Court

A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
May 12 2022

Mark Your Calendars! Time to Register for Pacific Mesothelioma Center's 11th Annual 5k Walk/Hike for Mesothelioma!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...

Continue Reading...
May 9 2022

BAP1 Genetic Mutation in Mesothelioma Warrants New Treatment Approaches

The University of Hawaii Cancer Center has published novel research on the BAP1 genetic mutation found in an estimated 10% of patients with mesothelioma with the goal of better understanding the unique traits of carriers of the mutation. Michele ...

Continue Reading...
May 6 2022

Hyperthermic Intrathoracic Chemotherapy is Associated with Longer Survival in Mesothelioma Patients

Researchers in the U.K. have published a systemic review analyzing 598 pleural mesothelioma patients that have undergone hyperthermic intrathoracic chemotherapy (“HITHOC”) immediately following surgery in the hopes of eradicating ...

Continue Reading...
May 6 2022

Chlorine Industry Opposes EPA Proposal to Ban Chrysotile Asbestos

Last month the Environmental Protection Agency under the Biden Administration announced a landmark proposal to ban the use, manufacture and import of Chrysotile asbestos in the United States, a move long coming since the US halted production of the ...

Continue Reading...
Apr 29 2022

Tackling the Asbestos that Lingers Behind in Buildings

Despite the recent EPA proposed ban on the use, manufacture and import of Chrysotile asbestos, the U.S. still faces the ongoing crisis of confronting the asbestos that remains in public buildings and homes. Also known as “legacy” ...

Continue Reading...
Apr 28 2022

Johnson & Johnson Shareholders to Vote to End Sales of Talc-Based Baby Powder Worldwide

Johnson & Johnson is being forced into a shareholder vote today, Thursday, April 28, at its 2022 Annual Shareholder meeting to end all sales of its talc-based baby powder globally. The company ceased sales of the product in the US and Canada in ...

Continue Reading...
125 results found. Viewing page 1 of 5. Go to page 1 2 3 4 5   Next

Get Empowered

We put your medical and personal needs first and provide compassionate representation.

Please enter the captcha above: